MedPath

The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and Progress

Not Applicable
Conditions
Malignant Tumors
Interventions
Other: Nutritional support with Standard diet
Other: Nutritional intervention with the Ketogenic diet
Registration Number
NCT01092247
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

The aim of the study is, to study the efficacy of the ketogenic diet in delaying or preventing recurrence and tumor growth progression of patients who have been previously treated by concomitant chemoradiotherapy (6 months) for high-grade glial tumors.

It will be an open-label trial of nutritional intervention for up to 1 year. An interim analysis of the data will be carried out to assess safety, compliance and efficacy of the diet. This will be reviewed by both SHS and the Clinical trial team.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard diet: Nutritional supportNutritional support with Standard diet-
Nutritional intervention: Ketogenic diet.Nutritional intervention with the Ketogenic diet-
Primary Outcome Measures
NameTimeMethod
To study the effect of the ketogenic diet on tumor growth progression and longevity in patients with Malignant glioblastoma.

This will be done by comparing tumor size by repeated MRI studies (every 2 months)

Secondary Outcome Measures
NameTimeMethod
Quality of life

Performance scale and quality of life evaluation (Karnofsky and EQ5D scale)

© Copyright 2025. All Rights Reserved by MedPath